Prostate Cancer

Baseball tournament in Corpus for Cancer awareness [Video]

The tournament will run through Sunday evening. Coach Akers said he hopes TM can host next years event, as well.

CORPUS CHRISTI, Texas — Over 90 Texas baseball teams are all in the Coastal Bend playing in a massive tournament, for one reason and one reason only; cancer awareness.

“The awareness part for me would be for me would be for everyone listening to go get your annual check ups,” said Todd Akers, the Head Baseball Coach of Tuloso-Midway.

About a year ago, from one blood test, Akers found out he had stage four prostate cancer.

“I had no symptoms whatsoever, you know?” he added.

For Rigo Rios whose kids play ball, baseball is more than a game it’s a gift.

“Lot of flashbacks of when my dad used to watch me play baseball because I was a baseball player too. That’s what brings us here,” said Rios.

Rios lost his mom and dad to cancer, so this tournament …

Watch/Read More
Prostate Cancer

PSMA Imaging: VISION Trial with Dr. Scott Tagawa [Video]

In this video, moderator Dr. Agarwal discusses the VISION trial with Dr. Scott Tagawa, a co-author on the New England Journal Medicine Paper on the primary results of the VISION Trial. They continue their discussion covering how lutetium-177 PSMA-617 will be incorporated into treating patients with metastatic CRPC. To end their conversation, Dr. Tagawa talks about how this agent and similar agents or approaches will be moving to other earlier states of prostate cancer.The Moderator: Neeraj Agarwal, MD, is an internationally recognized physician-scientist in the field of genitourinary cancers and is a Professor of medicine and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program and the Center of Investigational Therapeutics (CIT) at the HCI.The Panel of Experts: Dr. Jeremie Calais: Director of the UCLA Clinical theranostic Program and an Associate Professor at the Ahmanson Translational Theranostics Division of the Department of Molecular and Medical Pharmacology at UCLA. Dr. Calais received his MD degree from the University of Paris, France. He is a nuclear medicine physician specializing in cancer imaging and theranostics.Scott T. Tagawa, MD, MS, FACP: Professor of Medicine and Urology at Weill Cornell Medicine, and an Attending Physician at New York-Presbyterian – Weill Cornell Medical Center. As the Medical Director of the Genitourinary Oncology Research Program, Dr. Tagawa leads clinical trials in the areas of prostate, kidney, and bladder cancer as well as the prevention and treatment of thrombosis with cancer.Jonathan Tward, MD, Ph.D.: A tenured Professor in the Department of Radiation Oncology at the University of Utah who holds the Rudolph P. and Edna S. Reese Endowed Research Professorship. He is recognized as a major authority and key-opinion leader in treating prostate, bladder, and penile cancers. Dr. Tward is the leader of the Huntsman Cancer Institute's (HCI) Genitourinary Cancers Center (GUCC).